The bill, H.B. No. 3176, introduces new regulations concerning the manufacture, sale, and distribution of products developed using messenger ribonucleic acid (mRNA) material for the prevention or treatment of communicable diseases. Specifically, it adds Section 431.0215 to Subchapter B of Chapter 431 in the Health and Safety Code, defining "mRNA material" as a substance that introduces mRNA corresponding to a viral protein. The bill explicitly prohibits any person from manufacturing, selling, or distributing such products.

This legislation aims to establish clear guidelines and restrictions on the use of mRNA technology in health-related products, reflecting growing concerns about the safety and efficacy of these innovations. The provisions of the bill will take effect on September 1, 2025, allowing time for stakeholders to adjust to the new legal framework.

Statutes affected:
Introduced: ()